Skip to main content
SpringerLink
Log in

Comment on “Clinical effectiveness of surgical treatment after Lenvatinib administration for hepatocellular carcinoma”

  • Letter to the Editor
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Itoh S, Toshida K, Morita K et al (2022) Clinical effectiveness of surgical treatment after lenvatinib administration for hepatocellular carcinoma. Int J Clin Oncol 27(11):1725–1732. https://doi.org/10.1007/s10147-022-02229-2

    Article  CAS  PubMed  Google Scholar 

  2. Lui WY, Chau GY, Wu CW et al (1999) Surgical resection of hepatocellular carcinoma in elderly cirrhotic patients. Hepatogastroenterology. 46(26):640–5

    CAS  PubMed  Google Scholar 

  3. Shindoh J, Kawamura Y, Kobayashi Y et al (2021) Prognostic impact of surgical intervention after lenvatinib treatment for advanced hepatocellular carcinoma. Ann Surg Oncol 28:7663–7672. https://doi.org/10.1245/s10434-021-09974-0

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. The Aga Khan University, Stadium Road, P.O. Box 3500, Karachi, 74800, Pakistan

    Samar Sajid

Authors
  1. Samar Sajid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samar Sajid.

Ethics declarations

Conflict of interest

No author has any conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sajid, S. Comment on “Clinical effectiveness of surgical treatment after Lenvatinib administration for hepatocellular carcinoma”. Int J Clin Oncol 28, 610–611 (2023). https://doi.org/10.1007/s10147-023-02298-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-023-02298-x

Search

Navigation